Alnara Pharmaceuticals names new chief business officer
The appointment reflects Alnara’s growing operations as the company prepares to submit a new drug application and commercialize liprotamase, a novel, oral, porcine-free pancreatic enzyme replacement therapy that
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.